omalizumab treatment is discontinued. Patients who do not receive omalizumab receive maintenance OCS for the remainder of their life. Treatment Lifetime duration was Treatment horizon. based on the duration Treatment previous and time duration was effectiveness horizon assumed to be analyses of 10 years. omalizumab
omalizumab treatment is discontinued. Patients who do not receive omalizumab receive maintenance OCS for the remainder of their life. Treatment duration and time horizon Lifetime horizon. Treatment duration was assumed to be 10 years. Treatment duration was based on the previous analyses of omalizumab effectiveness
1-s2.0-S1098301514019330-mmc1.docx